HealthQuill Chronic Kidney Disease
Takeda Pharmaceuticalā€™s subsidiary, Shire Plc., was granted an FDA nod for making generic chewable tablets to treat attention-deficit, hyperactivity disorder, and moderate to severe binge disorder in adults.
Drugs Health Medical

Vitamin D deficiency linked to cardiovascular, CKD morbidity

HQ Team May 20, 2024: Vitamin D deficiency is associated with poor outcomes in cardiovascular diseases andĀ chronic kidney diseaseĀ (CKD) in patients with early-stage.

Read More
Novo Nordiskā€™s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24% of people involved in trials, the company announced.
Drugs Health Pharma

Novo Nordisk says Ozempic reduces kidney disease progressionĀ 

HQ Team March 6, 2024: Novo Nordiskā€™s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.

Read More
Drugs Health Pharma

Novo Nordisk to buy hypertension drug from KBP for $1.3 billion

HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.

Read More